Skip to main content
kainos loboratories,inc logo

kainos loboratories,inc — Investor Relations & Filings

Ticker · 4556 ISIN · JP3205650009 T Manufacturing
Open in API
Filings indexed 61 across all filing types
Latest filing 2026-04-22 Share Issue/Capital Cha…
Country JP Japan
Listing T 4556

About kainos loboratories,inc

https://www.kainos.co.jp/en/

Kainos Laboratories, Inc. is a company focused on the development, manufacture, marketing, and distribution of in-vitro diagnostics and pharmaceuticals. As a pioneer in its field, the company specializes in creating innovative clinical testing reagents for biochemical, immunological, and genetic analysis. These diagnostic tools are used to examine biological samples, such as blood and urine, to provide data on a patient's health status. The company is committed to developing and supplying novel products to meet the needs of the medical and healthcare communities.

Recent filings

Filing Released Lang Actions
臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese 臨時報告書 (“Timely Report”) filed under the Financial Instruments and Exchange Act, disclosing the Board resolution to convene an extraordinary shareholders’ meeting for a one-for-235,000 share consolidation (reverse stock split). It is not merely an announcement of an attached report but the full disclosure of a capital change event. This falls squarely under “Share Issue/Capital Change” (Code: SHA).
2026-04-22 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 51
2025-11-06 Japanese
半期報告書－第51期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by KAINOS Laboratories, Inc. in accordance with Article 24-5, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements (Balance Sheet, Income Statement, Cash Flow Statement) for the interim period ending September 30, 2025. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-11-06 Japanese
内部統制報告書－第50期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). It details the framework, scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting as of the fiscal year-end (March 31, 2025). This structure and content definitively classify it as a formal internal control report required under Japanese financial regulations, which corresponds most closely to the comprehensive annual reporting structure, although it is a specific component often filed alongside the 10-K equivalent or as a standalone mandatory filing in Japan. Given the options, this is a specific regulatory report focusing on internal controls, which is a key component of annual financial assurance. Since there is no specific code for a Japanese Internal Control Report, and it is a comprehensive report covering the entire fiscal year's control effectiveness, it aligns best with the scope of an Annual Report (10-K) or a detailed Audit/Regulatory Report (AR). However, since it is explicitly an 'Internal Control Report' based on the Financial Instruments and Exchange Act, and not a general 'Audit Report' (AR) or the full 'Annual Report' (10-K), I must check the definitions. The document is a formal, comprehensive report on internal controls, not just a brief announcement. In the context of US filings, this is often part of the 10-K. Given the specific nature, and lack of a direct match, I will evaluate if it fits AR (Audit Report / Information). An internal control report is closely related to the audit process. If it were a general regulatory filing, RNS would be used, but this is highly specific. Since it is a comprehensive report on financial reporting controls, it is a core component of annual financial disclosure, making 10-K the closest conceptual match for a comprehensive annual filing, but AR (Audit Report / Information) is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests'. An internal control report fits well within this scope as it relates directly to the assurance over financial statements. I will classify it as AR as it is a standalone report detailing the assessment framework and conclusion on controls, which is a form of assurance/audit information.
2025-06-20 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains Japanese characters and includes the header "有価証券報告書（通常方式）" which translates to 'Securities Report (Regular Format)'. It also explicitly mentions the submission under the Financial Instruments and Exchange Act (金融商品取引法) and confirms the accuracy of the '有価証券報告書' (Securities Report) for the fiscal year ending March 31, 2025. In the context of US/global filings, a comprehensive annual report covering full financial performance is typically classified as a 10-K. Since this document is a confirmation/cover sheet related to the annual securities report (which serves the function of a 10-K in Japan), and given the available codes, the closest equivalent for a comprehensive annual report is '10-K'. However, the document itself is a confirmation ('確認書') regarding the filing, not the full report. If the document were the full report, 10-K would be appropriate. Since it is a confirmation/cover page for the annual filing, and there isn't a specific code for a Japanese 'Yuka Shoken Hokokusho' confirmation, I must evaluate if it fits better as an announcement (RPA/RNS) or the report itself. Given the content confirms the contents of the full annual report, and the length is very short (569 chars), it strongly suggests this is an accompanying document or a cover page, not the full report. If the full report were attached, this would be RPA. Since it confirms the contents of the annual report, and '10-K' is the category for the Annual Report itself, I will classify it as 10-K based on the subject matter being the annual report confirmation, assuming the underlying document being referenced is the annual filing, but I acknowledge the short length suggests RPA might also be plausible if this were just an announcement *about* the filing. Given the explicit reference to the contents of the annual report being verified, 10-K is the most relevant category for the *subject* of the document. FY 2025
2025-06-20 Japanese
有価証券報告書－第50期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial data, business descriptions, and management information for the fiscal year ending March 31, 2025. This corresponds to the 10-K filing type in the provided schema. FY 2025
2025-06-20 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.